Table 2 Perioperative outcomes of patients with prostate cancer undergoing HoLEP, ThuLEP, and TURP.

From: Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study

Characteristic

HoLEP, n = 8160

ThuLEP, n = 2285

TURP, n = 211,323

Mortality

14 (0.2%)

Less than 3 cases

1816 (0.9%)

ICU admission

100 (1.2%)

19 (0.8%)

3658 (1.7%)

Transfusion

204 (2.5%)

58 (2.5%)

18,508 (8.8%)

Sepsis

50 (0.6%)

22 (1.0%)

2026 (1.0%)

Acute kidney disease

121 (1.5%)

35 (1.5%)

7203 (3.4%)

Postoperative incontinence

372 (4.6%)

68 (3%)

10,086 (4.8%)

Urinary retention

798 (9.8%)

206 (9%)

36,869 (17%)

Length of hospital stay (days)

4 (3–5)

3 (3–5)

6 (5–9)

  1. Variables are presented as median (interquartile range) or frequencies with proportions.
  2. HoLEP holmium laser enucleation of the prostate, ICU intensive care unit, ThuLEP thulium laser enucleation of the prostate, TURP transurethral resection of the prostate.
Back to article page